Federal contract award
75N94023F00001
75N94020D00009/75N94023F00001 - OVAPRENE VAGINAL DEVICE CLINICAL TRIAL - EMORY UNIVERSITY TITLE: OVAPRENE PHASE 1- PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAG
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | 75N94020D00009 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $105.6K |
| Current contract value | $105.6K |
| Potential contract value / ceiling | $105.6K |
| Start date | Sep 28, 2023 |
| Current end date | Dec 31, 2025 |
| Potential end date | Dec 31, 2025 |
| Latest award activity | Sep 29, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 29, 2025 | P00007 | $4.9K | NICHD: R&D: OVAPRENE PHASE 1- PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL: NON-SEVERABLE |
| Aug 29, 2025 | P00006 | $0 | NICHD: R&D: OVAPRENE PHASE 1- PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL: NON-SEVERABLE |
| Jun 11, 2025 | P00005 | $0 | NICHD: R&D: OVAPRENE PHASE 1- PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL: NON-SEVERABLE |
| May 30, 2025 | P00004 | $0 | NICHD: R&D: OVAPRENE PHASE 1- PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL: NON-SEVERABLE |
| May 1, 2025 | P00003 | $6.0K | NICHD: R&D: OVAPRENE PHASE 1- PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL: NON-SEVERABLE |
| Mar 20, 2025 | P00002 | $0 | NICHD: SERVICE: OVAPRENE PHASE 1- PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL: NON-SEVERABLE |
| Sep 26, 2024 | P00001 | $0 | 75N94020D00009/75N94023F00001 - OVAPRENE VAGINAL DEVICE CLINICAL TRIAL - EMORY UNIVERSITY TITLE: OVAPRENE PHASE 1- PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAG |
| Sep 22, 2023 | 0 | $94.7K | 75N94020D00009/75N94023F00001 - OVAPRENE VAGINAL DEVICE CLINICAL TRIAL - EMORY UNIVERSITY TITLE: OVAPRENE PHASE 1- PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAG |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.